Detalhe da pesquisa
1.
Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents.
J Chem Inf Model
; 63(4): 1301-1312, 2023 02 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36762429
2.
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations.
J Chem Inf Model
; 63(9): 2842-2856, 2023 05 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37053454
3.
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity.
J Chem Inf Model
; 63(21): 6900-6911, 2023 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37910792
4.
Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency.
J Chem Inf Model
; 62(11): 2771-2787, 2022 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35580195
5.
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines.
Biochem Pharmacol
; : 116161, 2024 Mar 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38522556
6.
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.
Sci Rep
; 14(1): 6491, 2024 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38499619
7.
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach.
Biochem Pharmacol
; 209: 115452, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36792038
8.
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions.
Eur J Med Chem
; 246: 114952, 2023 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36462439